文献速递其他结缔组织病

美洲原住民患干燥综合征风险更高且疾病活动度高于欧裔及非裔美国人

American Indians Have a Higher Risk of Sjögren's Syndrome and More Disease Activity Than European Americans and African Americans.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-07-05

该横断面研究纳入648例原发性干燥综合征患者,比较不同种族临床表现。美洲原住民占25.3%,远高于预期,但典型口眼干燥及抗Ro/SSA、抗La/SSB抗体较少,疾病活动度评分却更高。非裔美国人占比仅3.1%,但高球蛋白血症、血沉升高及腮腺肿大比例更高。

要点

  • 美洲原住民干燥综合征患病比例高,但典型症状和自身抗体少,易延误诊断。
  • 美洲原住民疾病活动度评分高于欧裔美国人,腺外表现以关节和腺体为主。
  • 非裔美国人高球蛋白血症、血沉升高和腮腺肿大需警惕淋巴瘤风险。

核心结论

  • 美洲原住民干燥综合征患病率高但缺乏典型特征,可能延误诊断。
  • 非裔美国人干燥综合征不常见且不更严重,但高球蛋白血症、血沉升高和腮腺肿大三联征需警惕淋巴瘤。

研究设计与样本

  • 横断面研究,纳入648例原发性干燥综合征患者:非裔美国人20例、美洲原住民164例、欧裔美国人426例、其他种族38例。
  • 患者来自多学科干燥综合征国际协作临床联盟研究门诊。

主要发现

  • 非裔美国人占干燥综合征队列3.1%,低于俄克拉何马州比例(P=3.01×10⁻⁵)、美国比例(P=2.24×10⁻¹³)及同机构系统性红斑狼疮队列比例(P=4.26×10⁻²⁷)。
  • 美洲原住民占干燥综合征队列25.3%,高于系统性红斑狼疮队列(P=3.17×10⁻⁹)、俄克拉何马州(P=6.36×10⁻²⁶)及美国人口(P=8.14×10⁻⁹⁶)的预期比例。
  • 美洲原住民异常泪液和唾液流率及抗Ro/SSA、抗La/SSB抗体阳性率较低。
  • 美洲原住民EULAR干燥综合征疾病活动度指数均值为3.77±4.78,高于欧裔美国人的2.90±4.12(P=0.011),腺外表现主要累及关节和腺体域。
  • 非裔美国人高球蛋白血症(OR 1.39 [95%CI 1.39-8.65];P=0.01)、血沉升高(OR 3.95 [95%CI 1.46-9.95];P=0.009)和腮腺肿大(OR 4.40 [95%CI 1.49-13.07];P=0.02)比例更高。

关键数值与推荐

  • 非裔美国人与欧裔美国人干燥综合征分类标准相似。
  • 美洲原住民异常泪液和唾液流率及抗Ro/SSA、抗La/SSB抗体阳性率低于欧裔美国人。

临床怎么用

  • 对美洲原住民干燥综合征应警惕非典型表现,避免漏诊。
  • 非裔美国人出现高球蛋白血症、血沉升高和腮腺肿大时需加强淋巴瘤监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the clinical and serologic manifestations of Sjögren's syndrome (SS) in ethnic groups of the US. METHODS: This was a cross-sectional study of 648 patients with primary SS: 20 African American (AA), 164 American Indian (AI), 426 European American (EA), and 38 patients of other races evaluated in a multidisciplinary Sjögren's International Collaborative Clinical Alliance research clinic. RESULTS: AA subjects comprised 3.1% of the SS cohort, much lower than the percentage of AA in the state of Oklahoma (P = 3.01 × E - 05), the US (P = 2.24E - 13), or a systemic lupus erythematosus (SLE) cohort at the same institution (P = 4.26 × 10E - 27). In contrast, the percentage of AI in the SS cohort (25.3%) was much higher than expected (P = 3.17E - 09 versus SLE cohort, P = 6.36 - 26 versus Oklahoma, and P = 8.14E - 96 versus US population). The SS classification criteria were similar between AA and EA, but subjects of AI ancestry had lower rates of abnormal tear and salivary flow, as well as anti-Ro/SSA and anti-La/SSB antibodies. Paradoxically, AI had higher levels of disease activity (mean ± SD European League Against Rheumatism Sjögren's Syndrome Disease Activity Index score 3.77 ± 4.78) in comparison to EA (2.90 ± 4.12; P = 0.011) and more extraglandular manifestations affecting mainly the articular and glandular domains. Meanwhile, AA patients were characterized by higher rates of hypergammaglobulinemia (odds ratio [OR] 1.39 [95% confidence interval (95% CI) 1.39-8.65]; P = 0.01), elevated erythrocyte sedimentation rate (ESR) (OR 3.95 [95% CI 1.46-9.95]; P = 0.009), and parotid enlargement (OR 4.40 [95% CI 1.49-13.07]; P = 0.02). CONCLUSION: AI are affected at high rates with SS but present with few classical features, potentially preventing timely diagnosis. In contrast to SLE, SS is infrequent and not more severe among AA, but the triad of hypergammaglobulinemia, increased ESR, and parotid enlargement warrants extra vigilance for lymphomagenesis.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Scofield RH, Sharma R, Pezant N, et al. American Indians Have a Higher Risk of Sjögren's Syndrome and More Disease Activity Than European Americans and African Americans. Arthritis Care Res (Hoboken). 2020. PMID: 31199565. doi:10.1002/acr.24003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。